Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)

NCT06079671 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

800

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced Cervical Cancer

Interventions

BIOLOGICAL: Volrustomig
OTHER: Placebo

Sponsor

AstraZeneca

Collaborators

[object Object]
[object Object]